Tesio, Saturnino .

HRN: 03-34-39  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/18/2025
11/25/2025
IV
2.25G
Q8H
Pneumonia
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Guideline Not Available

Initial appropriateness: No  Wrong Dose  Adjust According To EGFR

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: